The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury

Overview of attention for article published in Frontiers in Physiology, March 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 11,166 followers.

RT @FrontPhysiol: The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmon…

11 Jan 2022

Reply Repost Favourite

RT @PH_Papers: The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary…

11 Jan 2022

Reply Repost Favourite

The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury. https://t.co/WoPwFJz34p

11 Apr 2018

Reply Repost Favourite

04 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.